Funding for this research was provided by:
Canadian Institutes of Health Research (PJT-156225)
Received: 12 July 2019
Accepted: 15 June 2020
First Online: 23 June 2020
Ethics approval and consent to participate
: The study design was approved by the ethics committee of Alberta PCa Research Initiative (APCaRI) and informed consents were obtained in writing from all subjects for the APCaRI.
: Not applicable.
: MS and DC are co-founders of Montreal Epiterapia Inc. TAB is an Editorial Board member for the journal. The remaining authors declare that they have no conflict on interest.